Using Natural Language Processing (NLP) to Identify and Manage Patient Populations at Risk for Diabetes and Diabetic Complications

Using Natural Language Processing (NLP) to Identify and Manage Patient Populations at Risk for Diabetes and Diabetic Complications

Dr. James M. Maisel, (Doctor of Medicine)
Founder and Chairman
ZyDoc
USA

James M. Maisel, MD, CEO of ZyDoc, will be chairing the section of Epidemiology and Prevention of Diabetes at the 5th World Diabetes Congress in Prague, July 12-14, 2017, and lecturing on "Using Natural Language Processing (NLP) to Identify and Manage Patient Populations at Risk for Diabetes and its Complications."

Abstract

Diabetes is a major and growing chronic global health problem already afflicting hundreds of millions of people.  The diabetic population accounts for a significant health care burden and affects patients with dramatically increased morbidity and mortality.  To complicate matters, the number of prediabetic and diabetics is dramatically growing. While many prediabetics could benefit from preventative medicine with changes in lifestyle, diet, and early intervention, often they are not identified, and fail to receive screening or education about simple measures.  Many patients are already diabetic but are unaware that they have the disease until they develop complications. Treatment of complications is often complex, requires specialists and great attention to details and often fail to achieve ideal outcomes.

Despite the large numbers of diabetic patients and many scientific studies, we still do not know how best to identify those at risk for becoming diabetic, how to deter or slow the progression of diabetes and its complications.  Evidence based medicine tells us the most likely strategies and interventions to work overall but there is great variability of many factors and a wide range of disease progression.  Answering the important questions about populations and individuals requires standardized data and might best be addressed by building a Diabetic Clinical Data Repository.  This data repository would allow queries for assessing and managing diabetics in a scientific fashion based on large numbers of cases and multiple factors.

The talk will address how we might collect information as part of our current medical record practices and standardize the data using Natural Language Processing (NLP) stored in a Diabetic Clinical Data Repository.  The data repository would allow queries, analytic applications and use of Artificial Intelligence (AI) for individual and population management of those at risk for diabetes and its complications.  Large amounts of data should allow the healthcare system to recommend the best and lowest cost appropriate interventions at the ideal time to address the staggering diabetic healthcare threat.

Additional presentation for 5th World Diabetes Congress
Dr. Maisel will also present "Ocular Complications of Diabetes Mellitus and Laser, Surgery and Pharmacologic Treatment for Diabetic Retinopathy" at the 5th World Diabetes Congress in Prague. View the abstract at http://rgony.com/ocular-complications-diabetes-mellitus/

Biography

Dr. James M. Maisel, (Doctor of Medicine) is the Founder and Chairman of ZyDoc and The Retina Group of New York, USA. He is a Board Certified ophthalmologist who completed his Dyson Fellowship in vitreous and retinal surgery at New York-Presbyterian/Weill Cornell Medical Center, Residency in Ophthalmology at Nassau University Medical Center, Internship in Internal Medicine at Beth Israel Medical Center, Doctor of Medicine at New York Medical College, B.A. with Honors Chemistry at Kenyon College.

Dr. Maisel is also the Chairman of ZyDoc, a medical informatics and transcription company whose MediSapien software was ranked as one of the top five applications in The Data Design Diabetes Sanofi US Innovation Challenge.  In addition, he has been a clinical investigator, consultant, educator, and advisory board member for Pfizer, Novartis, EyeTech, TopCon, Genentech, Alimera, Regeneron and Allergan. He has pioneered the development of several innovations in medical informatics including one of the first prototypes of an EHR in 1993 that was sold to the Department of Defense. He served as Chairman of Healthcare Open Systems and Trials (HOST) prior to its merger with HIMSS and participated in development of standards and requirements for the medical informatics industry. ZyDoc speech recognition medical specialty language models were licensed to Dragon Systems in 1999 and ZyDoc created one of the first digital transcription systems in 2003. Under his leadership, ZyDoc has won numerous awards from the medical informatics, speech recognition, computing, transcription, and pharmaceutical industry. ZyDoc released its TrackDoc Connect Cloud based transcription platform with smartphone dictation app that allows doctors to dictate anywhere and automatically insert section level EHR data and derive structured data for document improvement, ICD-10 coding and analytics.

Dr. Maisel was Honored as the 2017 Humanitarian of the Year by the Juvenile Diabetes Research Foundation. He has served as a Corporate Advisory Board member for the Foundation of the American Academy of Ophthalmology (AAO) and the Juvenile Diabetes Foundation Medical Advisory Board.  He was also a member of the AAO Instrument and Device and Low Vision Committees and has received research grants from the U.S. Public Health Service and the National Institute of Health.  Dr. Maisel represented the National Society to Prevent Blindness at the ANSI Z-80 committee where he helped establish many ophthalmic industry standards.  He served as an editor of EyeCare Technology Magazine and Diabetes Technology Magazine, authored numerous professional journal articles, and lectures nationally on retina, medical informatics, and practice management topics.

  

Download the press release or read online.

Slide presentation by James M. Maisel, MD USA, CEO, ZyDoc / CEO, Retina Group of New York, presented at the 5th World Congress of Diabetes 2017, July 12-14, 2017, Prague, Czech Republic.

[Click on the image below to download a PDF.]

See also: Ocular Complications of Diabetes Mellitus and Laser, Surgery and Pharmacologic Treatment for Diabetic Retinopathy

ZyDoc Awards slide

Among numerous industry awards received by ZyDoc, MediSapien software was ranked as one of the top five applications in The Data Design Diabetes Sanofi US Innovation Challenge. (Press release)